Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with 90Y-Microspheres for Unresectable Liver Metastases

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Smits, Maarten L J ^a   van den Hoven, Andor F ^a   Rosenbaum, Charlotte E N M ^a   Zonnenberg, Bernard A ^a   Lam, Marnix G E H ^a   Nijsen, Johannes F W ^a   Koopman, Miriam ^a   van den Bosch, Maurice A A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ABDOMINAL PAIN; ADVERSE OUTCOME; ARTERY DISSECTION; ARTICLE; BACKACHE; CANCER GRADING; CANCER RISK; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; DUODENUM ULCER; FOLLOW UP; HEMATOMA; HUMAN; LIVER ANGIOGRAPHY; LIVER METASTASIS; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; RADIATION INDUCED LIVER DISEASE; RADIATION INJURY; RADIATION PNEUMONIA; RADIOCHEMOEMBOLIZATION; RISK ASSESSMENT; STOMACH ULCER; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84880825666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069448     Document Type: Article

References (34)

1. Bierman HR, Byron RL Jr, Kelley KH, Grady A, (1951) Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst 12: 107-131.
2. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, et al. (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88: 78-85.
3. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, et al. (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12: 1711-1720.
4. Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, et al. (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19: 951-959.
5. Dunfee BL, Riaz A, Lewandowski RJ, Ibrahim S, Mulcahy MF, et al. (2010) Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival. J Vasc Interv Radiol 21: 90-95.
6. Chua TC, Bester L, Saxena A, Morris DL, (2011) Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases. J Cancer Res Clin Oncol 137: 865-873.
7. Sato K, Lewandowski RJ, Bui JT, Omary R, Hunter RD, et al. (2006) Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29: 522-529.
8. Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE Jr, et al. (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65: 412-425.
9. Salem R, Thurston KG, (2006) Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 17: 1425-1439.
10. Szyszko T, Al-Nahhas A, Tait P, Rubello D, Canelo R, et al. (2007) Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 28: 21-24.
11. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, et al. (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68: 13-23.
12. Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, et al. (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20: 1121-1130; quiz 1131.
13. Carretero C, Munoz-Navas M, Betes M, Angos R, Subtil JC, et al. (2007) Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 102: 1216-1220.
14. Seidensticker R, Seidensticker M, Damm R, Mohnike K, Schutte K, et al. (2012) Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol 35: 1109-1118.
15. Sirtex (2013) SIR-Spheres Yttrium-90 Resin Microspheres Package Insert.
16. Barentsz MW, Vente MA, Lam MG, Smits ML, Nijsen JF, et al. (2011) Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates. Cardiovasc Intervent Radiol 34: 1074-1079.
17. Dezarn WA, Cessna JT, DeWerd LA, Feng W, Gates VL, et al. (2011) Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 38: 4824-4845.
18. Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Available: http://ctep.cancer.gov.
19. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247.
20. Reed GB Jr, Cox AJ Jr, (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48: 597-611.
21. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, et al. (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31: 1237-1248.
22. da Silveira EB, Jeffers L, Schiff ER, (2002) Diagnostic laparoscopy in radiation-induced liver disease. Gastrointest Endosc 55: 432-434.
23. Guha C, Kavanagh BD, (2011) Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol 21: 256-263.
24. Sempoux C, Horsmans Y, Geubel A, Fraikin J, Van Beers BE, et al. (1997) Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event. Hepatology 26: 128-134.
25. Piana PM, Gonsalves CF, Sato T, Anne PR, McCann JW, et al. (2011) Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center. J Vasc Interv Radiol 22: 1373-1379.
26. Gulec SA, Mesoloras G, Dezarn WA, McNeillie P, Kennedy AS, (2007) Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio. J Transl Med 5: 15.
27. Arslan N, Emi M, Alagoz E, Ustunsoz B, Oysul K, et al. (2011) Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center. Vojnosanit Pregl 68: 341-348.
28. Dudeck O, Wilhelmsen S, Ulrich G, Lowenthal D, Pech M, et al. (2012) Effectiveness of repeat angiographic assessment in patients designated for radioembolization using yttrium-90 microspheres with initial extrahepatic accumulation of technitium-99m macroaggregated albumin: a single center's experience. Cardiovasc Intervent Radiol 35: 1083-1093.
29. Smits ML, Nijsen JF, van den Bosch MA, Lam MG, Vente MA, et al. (2012) Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. Lancet Oncol 13: 1025-1034.
30. Lam MG, Banerjee S, Louie JD, Abdelmaksoud MH, Iagaru AH, et al. (2013) Root Cause Analysis of Gastroduodenal Ulceration After Yttrium-90 Radioembolization. Cardiovasc Intervent Radiol.
31. Louie JD, Kothary N, Kuo WT, Hwang GL, Hofmann LV, et al. (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20: 606-613.
32. Heusner TA, Hamami ME, Ertle J, Hahn S, Poeppel T, et al. (2010) Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo 182: 603-608.
33. Garin E, Rolland Y, Boucher E, Ardisson V, Laffont S, et al. (2010) First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation. Eur J Nucl Med Mol Imaging 37: 453-461.
34. Sharma RA, Wasan HS, Love SB, Dutton S, Stokes JC, et al. (2008) FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer. Clin Oncol (R Coll Radiol) 20: 261-263.